Allakos Announces Positive Phase 1 Results with Antolimab (AK002) in Mast Cell Gastrointestinal Disease
— Antolimab (AK002) reduced gastrointestinal symptoms by 64 percent in patients with mast cell gastrointestinal disease —— Management to host […]
— Antolimab (AK002) reduced gastrointestinal symptoms by 64 percent in patients with mast cell gastrointestinal disease —— Management to host […]
HINGHAM, Mass., March 24, 2020 (GLOBE NEWSWIRE) — Our Annual Meeting of Shareholders is scheduled for Thursday, April 30th, 2020 […]
Phase 3 study of antolimab for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis (previously referred to as eosinophilic gastroenteritis)Phase […]
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) — Fortress Transportation and Infrastructure Investors LLC (“NYSE:FTAI”) today announced that its 2019 […]
MONTRÉAL, 24 mars 2020 (GLOBE NEWSWIRE) — Jean-Jacques Ruest, président-directeur général du CN, et Ghislain Houle, vice-président exécutif et chef […]
MONTREAL, March 24, 2020 (GLOBE NEWSWIRE) — JJ Ruest, President and Chief Executive Officer and Ghislain Houle, Executive Vice-President and […]
RICHMOND, Calif., March 24, 2020 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of […]
The Company is currently experiencing minimal impact on ongoing business and operations during this period NEW YORK, March 24, 2020 (GLOBE […]
ROUYN-NORANDA, Québec, March 24, 2020 (GLOBE NEWSWIRE) — GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, […]
ISELIN, N.J., March 24, 2020 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ:MSEX) has announced that despite the current COVID-19 crisis, […]